Listen to insights on haematology data, as discussed by experts in the field
EHA 2020 Congress - Follicular Lymphoma Highlights
Listen to Dr Wendy Osborne and Professor Emmanuel Bachy discussing Follicular Lymphoma treatment optimisation with a patient case study. The presentation has been taken from a global Roche symposium at EHA 2020.
Duration 12 min 36 sec.
HaemLIVE 2019 National Meeting
Listen to Dr William Townsend and Dr Wendy Osborne discuss the GALLIUM 4-year follow-up results, and the clinical relevance of endpoints. Duration 38 min 51 sec.
Listen to Dr George Follows, Dr Wendy Osborne and Dr William Townsend discuss chemotherapy backbone and anti-CD20 antibody choice. Duration 3 min 27 sec.
Listen to Dr William Townsend discuss PET & MRD from the GALLIUM trial, and the relevance of having minimal residual disease, from Haem Live 2019. Duration 5 min 45 sec.
Listen to Dr William Townsend discuss the Quality of Life data from the GALLIUM trial. Duration 52 sec.
The first video in the HaemLIVE 2019 National Meeting series is CPD accredited. You will be able to download your certificate when you have watched the entire video.
Prof. Andrew Davies responds to FAQs from GALLIUM
Listen to Prof. Andrew Davies discuss FAQs about GALLIUM, including the study design and efficacy vs safety.
Duration 4 min 43 sec.
Listen to Prof. Andrew Davies discuss the benefit of using Gazyvaro over Rituximab in 1L FL patients.
Duration 1 min 25 sec.
Listen to Prof. Andrew Davies discuss his experience with Gazyvaro, and the endpoints from the GALLIUM trial.
Duration 1 min 17 sec.
Retrospective sub-analysis of GALLIUM in patients with FLIPI scores ≥2.
A discussion including Prof Russell Patmore, Dr Wendy Osborne and Dr Graham Collins exploring the findings from the retrospective sub-analysis of the GALLIUM study in patients with FLIPI scores ≥2. Duration 2 min 14 sec.
1L, first-line; CLL, chronic lymphocytic leukaemia; FAQs, frequently asked questions; FL, follicular lymphoma; FLIPI, Follicular Lymphoma International Prognostic Index; MRD, minimal residual disease; PET, positron emission tomography.
Date of preparation: July 2020